CEP-28122 mesylate salt, a diaminopyrimidine derivative, is a potent, selective, and orally bioavailable ALK (anaplastic lymphoma kinase) inhibitor with an IC50 value of 1.9 nM against recombinant ALK kinase activity. It shows antitumor efficacy in ALK-positive human cancer models and has favorable pharmacodynamic and pharmacokinetic profiles.
Molecular Weight:
635.17
Formula:
C29H39ClN6O6S
Target:
Others|||ALK
T72317
* VAT and and shipping costs not included. Errors and price changes excepted
